Who invested in Jnana Therapeutics?
Jnana Therapeutics's investors include Polaris Partners, RA Capital Management, Versant Ventures, AbbVie and Bain Capital Life Sciences.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$107Mraised across 1 round since 2022, from 1 source
Source recordedSEC filing: $60M sold, first sale Nov 2022
From Jnana Therapeutics's own website and the SEC filings it signed: 1 founder, 5 on the team.
On the board, as filediAnnie C. ChenBrian M. CaliCarlo W. RizzutoDonald W. NicholsonMatthew W. HammondRonald C. RenaudTerrance G. McGuire
Jnana Therapeutics's investors include Polaris Partners, RA Capital Management, Versant Ventures, AbbVie and Bain Capital Life Sciences.
Jnana Therapeutics has raised $107M across 1 round since 2022.
Jnana Therapeutics's most recent round was a Series C of $107M in Nov 2022.
Its most recent round, $107M in Nov 2022, is also its largest on record.
Jnana Therapeutics's first round on record, in Nov 2022, was backed by Polaris Partners, RA Capital Management and Versant Ventures and 2 others.
Jnana Therapeutics's latest named round is a Series C, in Nov 2022.
Jnana Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.